Medifast (MED) Asset Writedowns and Impairment (2011 - 2020)

Medifast has reported Asset Writedowns and Impairment for 7 years, with the latest figure at $48000.0 in Q4 2020.

• For the quarter ending Q4 2020, Asset Writedowns and Impairment fell 88.81% year-over-year to $48000.0; the trailing twelve-month figure through Dec 2020 stood at $7.0 million (up 0.69% YoY), and the FY2020 full-year result was $556000.0, down 84.72% from the prior year.
• Asset Writedowns and Impairment for Q4 2020 stood at $48000.0, down from $429000.0 in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $6.1 million in Q2 2016, with the low at $48000.0 in Q4 2020.
• Historically, Asset Writedowns and Impairment has averaged $2.6 million across 5 years, with a median of $429000.0 in 2019.
• Annual changes were most pronounced in 2019 — Asset Writedowns and Impairment increased 3.12% — and 2020, when it plunged 88.81%.
• Medifast's Asset Writedowns and Impairment stood at $6.1 million in 2016, then changed by 0.0% to $6.1 million in 2017, then sank by 93.18% to $416000.0 in 2018, then advanced by 3.12% to $429000.0 in 2019, then sank by 88.81% to $48000.0 in 2020.
• The last three Asset Writedowns and Impairment figures came in at $48000.0 (Q4 2020), $429000.0 (Q4 2019), and $416000.0 (Q4 2018), per Business Quant data.